Treating Neovascular Age-Related Macular Degeneration in the Era of COVID-19

Graefe's Archive for Clinical and Experimental Ophthalmology- Germany

doi 10.1007/s00417-020-04693-w

Full Text

Abstract

Available in

Categories

Molecular Neuroscience

Sensory Systems

Date

April 21, 2020

Authors

Publisher

Springer Science and Business Media LLC

Related search

Macular Atrophy in Neovascular Age Related Macular Degeneration

Journal of Clinical Review & Case Reports

English

Aflibercept for Neovascular Age-Related Macular Degeneration

Cochrane Database of Systematic Reviews

Norwegian Bokmål

Treatment of Age-Related Neovascular Macular Degeneration: The Patient’s Perspective

Graefe's Archive for Clinical and Experimental Ophthalmology

Molecular Neuroscience

Sensory Systems

English

Role of Interleukin 33 in Neovascular Age-Related Macular Degeneration

English

Cost-Effectiveness of Intravitreal Aflibercept Injection (IAI) in Treating Neovascular Age-Related Macular Degeneration in the US

Value in Health

Occupational Health

English

Patient Preferences in the Treatment of Neovascular Age-Related Macular Degeneration

English

Visual Outcomes in Patients With Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica

English

Ranibizumab Versus Verteporfin for Neovascular Age-Related Macular Degeneration

New England Journal of Medicine

English

Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular Degeneration

Ophthalmology and Therapy

English